AAAAAA

   
Results: 1-11 |
Results: 11
Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression
Authors: Huber, JD Witt, KA Hom, S Egleton, RD Mark, KS Davis, TP
Citation: Jd. Huber et al., Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression, AM J P-HEAR, 280(3), 2001, pp. H1241-H1248
Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier
Authors: Huber, JD Egleton, RD Davis, TP
Citation: Jd. Huber et al., Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier, TRENDS NEUR, 24(12), 2001, pp. 719-725
Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation
Authors: Egleton, RD Mitchell, SA Huber, JD Palian, MM Polt, R Davis, TP
Citation: Rd. Egleton et al., Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation, J PHARM EXP, 299(3), 2001, pp. 967-972
Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE)
Authors: Witt, KA Huber, JD Egleton, RD Roberts, MJ Bentley, MD Guo, LH Wei, HB Yamamura, HI Davis, TP
Citation: Ka. Witt et al., Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE), J PHARM EXP, 298(2), 2001, pp. 848-856
Effect of reduced flow on blood-brain barrier transport systems
Authors: Hom, S Egleton, RD Huber, JD Davis, TP
Citation: S. Hom et al., Effect of reduced flow on blood-brain barrier transport systems, BRAIN RES, 890(1), 2001, pp. 38-48
Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect
Authors: Witt, KA Huber, JD Egleton, RD Davis, TP
Citation: Ka. Witt et al., Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect, J PHARM EXP, 295(3), 2000, pp. 972-978
Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin
Authors: Witt, KA Slate, CA Egleton, RD Huber, JD Yamamura, HI Hruby, VJ Davis, TP
Citation: Ka. Witt et al., Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin, J NEUROCHEM, 75(1), 2000, pp. 424-435
Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability
Authors: Bilsky, EJ Egleton, RD Mitchell, SA Palian, MM Davis, P Huber, JD Jones, H Yamamura, HI Janders, J Davis, TP Porreca, F Hruby, VJ Polt, R
Citation: Ej. Bilsky et al., Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability, J MED CHEM, 43(13), 2000, pp. 2586-2590
Improved bioavailability to the brain of glycosylated Met-enkephalin analogs
Authors: Egleton, RD Mitchell, SA Huber, JD Janders, J Stropova, D Polt, R Yamamura, HI Hruby, VJ Davis, TP
Citation: Rd. Egleton et al., Improved bioavailability to the brain of glycosylated Met-enkephalin analogs, BRAIN RES, 881(1), 2000, pp. 37-46
The effect of halogenation on blood-brain barrier permeability of a novel peptide drug
Authors: Gentry, CL Egleton, RD Gillespie, T Abbruscato, TJ Bechowski, HB Hruby, VJ Davis, TP
Citation: Cl. Gentry et al., The effect of halogenation on blood-brain barrier permeability of a novel peptide drug, PEPTIDES, 20(10), 1999, pp. 1229-1238
Transport of the delta-opioid receptor agonist [D-penicillamine(2,5)] enkephalin across the blood-brain barrier involves transcytosis
Authors: Egleton, RD Davis, TP
Citation: Rd. Egleton et Tp. Davis, Transport of the delta-opioid receptor agonist [D-penicillamine(2,5)] enkephalin across the blood-brain barrier involves transcytosis, J PHARM SCI, 88(4), 1999, pp. 392-397
Risultati: 1-11 |